Enhanced enzymatic synthesis of the enantiopure intermediate for the blockbuster drug intermediate abacavir through a two-step enzymatic cascade reaction

Tetrahedron Asymmetry

Volumn 27, Issue 16, 2016, Pages 729-731

  Galla, Zsolt ^a   Forró, Enikő ^a   Fülöp, Ferenc ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 AZABICYCLO[2.2.1]HEPT 5 EN 3 ONE; ABACAVIR; GAMMA LACTAM DERIVATIVE; N HYDROXYMETHYL 2 AZABICYCLO[2.2.1]HEPT 5 EN 3 ONE; N HYDROXYMETHYL 2 AZABICYCLO[2.2.1]HEPTAN 3 ONE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS ORYZAE; CANDIDA ANTARCTICA; DRUG SYNTHESIS; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RACEMIC MIXTURE; RING OPENING; SUBMERGED FERMENTATION;

EID: 84979502263     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2016.06.019     Document Type: Article

References (22)

1. 1 Companyo, X., Geant, P., Mazzanti, A., Moyano, A., Rios, R., Tetrahedron 70 (2014), 75–82.
2. 2 Tan, Y., Yang, X., Liu, W., Sun, X., Tetrahedron Lett. 55 (2014), 6105–6108.
3. 3 Gao, S., Zhu, S., Huan, R., Lu, Y., Zheng, G., Bioorg. Med. Chem. Lett. 25 (2015), 3878–3881.
4. 4 Szakonyi, Z., Csőr, Á., Haukka, M., Fülöp, F., Tetrahedron 71 (2015), 4846–4852.
5. 5 Singh, R., Vince, R., Chem. Rev. 112 (2012), 4642–4686.
6. 6 Taylor, S.J.C., McCague, R., Wisdom, R., Lee, C., Dickson, K., Ruecroft, G., O'Brien, F., Littlechild, J., Bevan, J., Roberts, S.M., Evans, C., Tetrahedron: Asymmetry 4 (1993), 1117–1128.
7. 7 Stuart, J.W.T.C., Boucher, C.A.B., Cooper, D.A., Galasso, G.J., Richman, D.D., Thomas, H.C., Whitley, R.J., Antiviral Res. 38 (1998), 75–93.
8. 8 Evans C. T.; Roberts S. M.; Stanley M. Eur. Pat. Appl. EP 424064 A17 1991, pp 7.
9. 9 Forró, E., Galla, Z., Fülöp, F., Eur. J. Org. Chem. 15 (2016), 2647–2652.
10. 10 Forró, E., Fülöp, F., Org. Lett. 5 (2003), 1209–1212.
11. 11 Forró, E., Fülöp, F., Curr. Med. Chem. 19 (2012), 6178–6187.
12. 12 Forró, E., Fülöp, F., Mini-Rev. Org. Chem. 1 (2004), 93–102.
13. 13 Forró, E., Fülöp, F., Eur. J. Org. Chem. 31 (2008), 5263–5268.
14. 14 Forró, E., Fülöp, F., Tetrahedron: Asymmetry 12 (2001), 2351–2358.
15. −1; 140 kPa; retention times (min), (1S,4R)-6: 27.38 (antipode: 27.84)], (1R,3S)-8: 28.74 (antipode: 28.98)].
16. 16 Forró, E., J. Chromatogr., A 1216 (2009), 1025–1029.
17. 2: C, 56.68; H, 7.13; N, 11.02; found: C, 56.74; H, 7.14; N, 10.97.
18. 2: C, 55.80; H, 8.58; N, 10.84; found: C, 55.78; H, 8.60; N, 10.84.
19. 19 Nakano, H., lwasa, K., Okuyama, Y., Hongo, H., Tetrahedron: Asymmetry 7 (1996), 2381–2386.
20. 2·HCl: C, 43.51; H, 7.30; N, 8.46; found: C, 43.61; H, 7.35; N, 8.41.
21. 21 Forró, E., Árva, J., Fülöp, F., Tetrahedron: Asymmetry 12 (2001), 643–649.
22. 9NO: C, 64.84; H, 8.16; N, 12.60; found: C, 64.81; H, 8.13; N, 12.68.